Express Scripts Holding Company Strategy, SWOT and Corporate Finance Report [Report Updated: 01082017] Prices from USD $175
Express Scripts Holding Company Strategy, SWOT and Corporate Finance Report
Summary
Express Scripts Holding Company Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.
Key Highlights
Express Scripts Holding Company ESRX or 'the company', the largest pharmacy benefit management PBM company in the US, was created in 2012 through the merger of Express Scripts ESI and Medco Health Solutions Medco. ESRX also operates in Canada. It is headquartered in St. Louis, Missouri.
Scope
Detailed information on Express Scripts Holding Company required for business and competitor intelligence needs
A study of the major internal and external factors affecting Express Scripts Holding Company in the form of a SWOT analysis
An indepth view of the business model of Express Scripts Holding Company including a breakdown and examination of key business segments
Intelligence on Express Scripts Holding Company's mergers and acquisitions MandA, strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about Express Scripts Holding Company, such as business expansion, restructuring, and contract wins
Large number of easytograsp charts and graphs that present important data and key trends
Reasons to buy
Gain understanding of Express Scripts Holding Company and the factors that influence its strategies.
Track strategic initiatives of the company and latest corporate news and actions.
Assess Express Scripts Holding Company as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on Express Scripts Holding Company's business structure, strategy and prospects.
Original Article: Express Scripts Holding Company Strategy, SWOT and Corporate Finance Report [Report Updated: 01082017] Prices from USD $175
